Today: 3 July 2026
Browse Category

NYSE:FMC 30 October 2025 - 10 February 2026

$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

Market Jitters: Fed and AI Bubble Fears Sink DAX Below 24,000

After a solid start on Monday, Germany’s DAX index abruptly reversed course on Tuesday, dropping about 1.5% and falling below the 24,000-point thresholdfinanzen.net. By midday, the DAX sank to around 23,750 points, giving up most of the prior session’s gains. This decline was in line with a broader market pullback: France’s CAC 40 was down roughly 1.3% and London’s FTSE 100 about 0.8% in the same sessiontimesofindia.indiatimes.com. The sudden slump underscores how fragile recent gains have been – the DAX has been range-bound for months, and each attempt to rally has quickly met resistancerss-verzeichnis.de. “The sideways movement continues,” noted one analyst, who said only a slew of upbeat earnings reports might provide reliefhandelsblatt.com. In other words, without fresh positive catalysts, the market’s momentum fizzled out almost as quickly as it started. Analysts pointed out that the 24,000 level has become a psychologically important barrier for the German indexdeineschlagerwelt.de. The DAX briefly popped above that mark during the latest uptick, but Tuesday’s selling drove it right back down, confirming 24,000 as a formidable hurdle in the current environmentdeineschlagerwelt.de. The MDAX of mid-sized German stocks likewise fell over 1.4%, and the pan-European Euro Stoxx 50 index dropped by a similar magnitudefinanzen.net. This
4 November 2025
···
FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Corporation stunned the market with a far worse-than-expected third quarter, driven by a massive one-time hit in its international operations. The Philadelphia-based crop protection company reported a GAAP net loss of $569.3 million for Q3 2025, a dramatic swing from a $65 million profit in the same quarter last year Benzinga. The red ink stems largely from FMC’s troubled India business, which the firm is preparing to divest. FMC took a $510 million write-down on the India unit’s value and associated assets, writing its carrying value down from about $960 million to $450 million Benzinga. In addition, FMC recorded pre-sale adjustments of roughly $282 million, including product return costs and pricing concessions designed to accelerate collections in India Benzinga. These charges pushed FMC deep into the red and underscore the severity of the issues in that market. Even apart from the India debacle, FMC’s core business showed strain. Revenue collapsed 49% year-over-year to just $542 million for the quarter Benzinga. The company attributed the plunge primarily to those one-time India actions. However, excluding India, sales still fell ~4% on a like-for-like basis Benzinga, indicating broader softness. FMC noted pricing pressure as a key factor – overall prices were down
30 October 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 30.10.2025

ENDEDLive coverage has endedEnded: October 31, 2025, 12:00 AM EDT Liberty Latin America (LILA) Valuation Under Scrutiny as Shares Slide Despite Solid Fundamentals October 30, 2025, 10:36 PM EDT. Liberty Latin America (LILA) has fallen ~6% over the last month despite solid annual revenue growth and a rebound in net income. Its 1-year total shareholder return is down >20%, even after a strong rally earlier this year and a ~21% YTD gain. The stock trades at a discount to analyst targets, with a fair value around $10.63 versus a recent close near $7.77, suggesting an undervalued setup for patient investors.
30 October 2025
·······

Stock Market Today

  • Asahi Kasei (TSE:3407) wraps up ¥17.86bn buyback, highlights pharma tech scale-up
    July 3, 2026, 4:32 PM EDT. Asahi Kasei (TSE:3407) finished a ¥17.86 billion buyback, taking in 0.75% of its shares and signaling a focus on returns for shareholders. Peptistar has now launched Asahi Kasei's FO-MD system at the plant level, putting its pharmaceutical concentration tech into real-world production. This push could drive earnings through healthcare and process solutions, adding to its main battery and hydrogen businesses. Some risks remain for executing FO-MD and AK1940 at scale. The stock has moved up, but some see valuation still lagging-with fair value estimates pointing to a possible double from here. The story here is tighter capital discipline and a bigger bet on new technology.
Go toTop